Veratramine
Veratramine exhibits cytotoxic activity against human tumor cell lines A549, PANC-1, SW1990 and NCI-H249. Veratramine shows hypotensive effect, the effect is directly positively correlated with the dosage.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Curr Issues Mol Biol.2022, 44(5):2300-2308.
Molecules.2019, 24(24):E4536
Molecules.2024, 29(5):1048.
Phytomedicine.2018, 38:45-56
Neuropharmacology.2018, 131:68-82
J Drug Delivery Science and Tech.2022, 67:102957.
J of Physics Conference Series2019, 1349(1)
Viruses.2024, 16(7):1128.
Antioxidants (Basel).2021, 10(11):1831.
Korean Journal of Pharmacognosy2019, 50(4):285-290
Related and Featured Products
Phytother Res. 2008 Aug;22(8):1093-6.
Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum.[Pubmed:
18570211 ]
METHODS AND RESULTS:
The antitumor activity of six extracts (ethanol extract, petroleum ether fraction, CHCl(3) fraction, ethyl acetate fraction, n-butanol fraction and total alkaloids) from the rhizomes of Veratrum dahuricum, and six compounds (Veratramine (1), jervine (2), germine (3), veramitaline (4), veratrosine (5) and cyclopamine (6)) from the ethanol extract were investigated in vitro. The 12 samples exhibited cytotoxic activity against human tumor cell lines A549, PANC-1, SW1990 and NCI-H249.
CONCLUSIONS:
Among these samples, CHCl(3) fraction, the total alkaloids, compounds 1 and 6 showed higher inhibitory activity, compound 3 selectively exhibited significant cytotoxicity to SW1990 and NCI-H249.
Pharmazie. 2008 Aug;63(8):606-10.
Hypotensive effect and toxicology of total alkaloids and veratramine from roots and rhizomes of Veratrum nigrum L. in spontaneously hypertensive rats.[Pubmed:
18771011]
METHODS AND RESULTS:
Total alkaloids (VTA) and Veratramine of Veratrum nigrum L. were tested for hypotensive effect using spontaneously hypertensive rats (SHR). Acute toxicities were also evaluated. There was a dose-dependent reduction in blood pressure and heart rate after a single ingestion (1.0 to 4.0 mg/kg, intragastric administration) of VTA. A single oral ingestion (0.56 to 2.24 mg/kg) of Veratramine, the major component of VTA, dose-dependently decreased blood pressure and heart rate, suggesting that Veratramine was involved in the hypotensive effect of VTA in SHR.
CONCLUSIONS:
The hypotensive effects of VTA and Veratramine are directly positively correlated with the dosage. Side effects were not obvious.
AAPS J. 2016 Mar;18(2):432-44.
Gender-Dependent Pharmacokinetics of Veratramine in Rats: In Vivo and In Vitro Evidence.[Pubmed:
26791530]
Veratramine, a major alkaloid from Veratrum nigrum L., has distinct anti-tumor and anti-hypertension effects. Our previous study indicated that Veratramine had severe toxicity toward male rats.
METHODS AND RESULTS:
In order to elucidate the underling mechanism, in vivo pharmacokinetic experiments and in vitro mechanistic studies have been conducted. Veratramine was administrated to male and female rats intravenously via the jugular vein at a dose of 50 μg/kg or orally via gavage at 20 mg/kg. As a result, significant pharmacokinetic differences were observed between male and female rats after oral administration with much lower concentrations of Veratramine and 7-hydroxyl-Veratramine and higher concentrations of Veratramine-3-O-sulfate found in the plasma and urine of female rats. The absolute bioavailability of Veratramine was 0.9% in female rats and 22.5% in male rats. Further experiments of Veratramine on Caco-2 cell monolayer model and in vitro incubation with GI content or rat intestinal subcellular fractions demonstrated that its efficient passive diffusion mediated absorption with minimal intestinal metabolism, suggesting no gender-related difference during its absorption process. When Veratramine was incubated with male or female rat liver microsomes/cytosols, significant male-predominant formation of 7-hydroxyl-Veratramine and female-predominant formation of Veratramine-3-O-sulfate were observed.
CONCLUSIONS:
In conclusion, the significant gender-dependent hepatic metabolism of Veratramine could be the major contributor to its gender-dependent pharmacokinetics.
